Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Fragment-based discovery enables direct targeting of the melanoma oncogene MITF.
Journal: Nature communications
Published: November 10, 2024
Development of a p62 biodegrader for autophagy targeted degradation.
Journal: Nature communications
Published: October 21, 2024
mRNA Display Identifies Potent, Paralog-Selective Peptidic Ligands for ARID1B.
Journal: ACS chemical biology
Published: April 24, 2024
Discovery of Ligands for TRIM58, a Novel Tissue-Selective E3 Ligase.
Journal: ACS medicinal chemistry letters
Published: June 12, 2023
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field.
Journal: ACS medicinal chemistry letters
Published: April 12, 2023
PAX8 and MECOM are interaction partners driving ovarian cancer.
Journal: Nature communications
Published: July 27, 2020
Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach.
Journal: ACS medicinal chemistry letters
Published: December 23, 2016
Optimization of a Fragment-Based Screening Hit toward Potent DOT1L Inhibitors Interacting in an Induced Binding Pocket.
Journal: ACS medicinal chemistry letters
Published: April 21, 2016
HMGCR rs17671591 SNP Determines Lower Plasma LDL-C after Atorvastatin Therapy in Chilean Individuals.
Journal: Basic & clinical pharmacology & toxicology
Published: May 11, 2015
Affordable uniform isotope labeling with (2)H, (13)C and (15)N in insect cells.
Journal: Journal of biomolecular NMR
Published: March 16, 2015
Last Updated: 09/26/2026